共 50 条
- [1] Update: Meta-analysis of Overall Risk for Lymphoma with Immunomodulators for Inflammatory Bowel Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S423 - S424
- [2] A Meta-analysis of Age-specific Risk for Lymphoma with Immunomodulators for Inflammatory Bowel Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S454 - S454
- [3] Risk of lymphoma: inflammatory bowel disease and immunomodulators [J]. GUT, 2006, 55 (04) : 580 - 581
- [4] Lymphoma in inflammatory bowel disease: baseline risk and influence of immunomodulators [J]. IBD AND SALICYLATES - 5, 2001, 24 (01): : 45 - 49
- [5] A meta-analysis of the risk of osteoporotic fractures in inflammatory bowel disease [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (04): : 327 - 333
- [6] Inflammatory bowel disease and risk of cervical cancer: a meta-analysis [J]. International Journal of Colorectal Disease, 2014, 29 : 1023 - 1024
- [7] Dietary fat and risk of inflammatory bowel disease: a meta-analysis [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11072 - 11077
- [10] Risk of pancreatitis in patients with inflammatory bowel disease - a meta-analysis [J]. DANISH MEDICAL JOURNAL, 2020, 67 (03):